The expression of large and small vessel disease in type 2 diabetes differs
from that observed in type 1, with a higher prevalence of atherosclerosis
and hypertension, maculopathy rather than proliferative retinopathy, and ne
phropathy of a more complex nature. Such differences are mirrored by differ
ences in vascular pathophysiology with an early impairment of microvascular
vasodilatory reserve being a prominent feature. The defect appears to be e
ndothelium dependent and in conjunction with evidence of endothelium activa
tion suggests that the endothelium plays a crucial role in the pathogenesis
of vascular disease in type 2 diabetes and may even be an intrinsic featur
e or common antecedent of the insulin resistance syndrome. Several cellular
mechanisms may be proposed linking insulin resistance and endothelial dysf
unction including (i) abnormalities of common signal transduction mechanism
s, (ii) alterations in cell membrane fluidity altering the expression and/o
r presentation of a wide range of receptors, or (iii) changes in oxidative
stress. It is intuitively unlikely that the alteration of a single signal t
ransduction mechanism could be a common cause, particularly as aspects of e
ndothelial dysfunction implicate different mechanisms. Accordingly, changes
in oxidative stress, either stemming from glucose-mediated increased free-
radical generation and/or reduction of antioxidant capacity, are strong con
tender mechanisms. Not only may increased oxidative stress result in the qu
enching of nitric oxide, neutralizing its many protective functions, but it
may also damage DNA, protein structure, and membrane properties. Elucidati
ng the links between oxidative stress, endothelial function, and insulin re
sistance has important implications for the prevention of diabetic angiopat
hy and perhaps for the prevention of diabetes itself. (C) 2000 Elsevier Sci
ence Inc. All rights reserved.